von Guggenberg, E.; Kolenc, P.; Rottenburger, C.; Mikołajczak, R.; Hubalewska-Dydejczyk, A.
Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals. Cancers 2021, 13, 5776.
https://doi.org/10.3390/cancers13225776
AMA Style
von Guggenberg E, Kolenc P, Rottenburger C, Mikołajczak R, Hubalewska-Dydejczyk A.
Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals. Cancers. 2021; 13(22):5776.
https://doi.org/10.3390/cancers13225776
Chicago/Turabian Style
von Guggenberg, Elisabeth, Petra Kolenc, Christof Rottenburger, Renata Mikołajczak, and Alicja Hubalewska-Dydejczyk.
2021. "Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals" Cancers 13, no. 22: 5776.
https://doi.org/10.3390/cancers13225776
APA Style
von Guggenberg, E., Kolenc, P., Rottenburger, C., Mikołajczak, R., & Hubalewska-Dydejczyk, A.
(2021). Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals. Cancers, 13(22), 5776.
https://doi.org/10.3390/cancers13225776